|
LIBERTY CORNER, N.J., Aug. 8 /PRNewswire/ -- GeneraMedix
Inc. has
launched Fosphenytoin Sodium Injection, USP.
GeneraMedix Inc. Launches Fosphenytoin Sodium Injection,
USP
GeneraMedix offers Fosphenytoin Sodium Injection, USP,
50 mg PE*/mL in
2 and 10 mL vials, preservative free.
Ronald F. Quadrel, President and CEO of GeneraMedix Inc.
stated, "Fosphenytoin represents
our fifth generic injectable product launch in the
last two months. Our portfolio of product offerings continues
to grow at a
very rapid pace. We are continuing to develop and file
additional
Abbreviated New Drug Applications (ANDAs) for many other
generic
injectables and expect to further expand and diversify
our injectable
product line."
About GeneraMedix Inc.
GeneraMedix Inc. is a privately held pharmaceutical company
offering
high quality generic injectable products to the U.S. hospital
and specialty
markets. In addition to its products already marketed,
GeneraMedix has a
significant number of injectable products under development,
as well as a
number of products currently under FDA review. Headquartered
in Liberty
Corner, New Jersey, the company was founded in July of
2004. Additional
information is available on the company's website at http://www.generamedix.com.
* PE = phenytoin sodium equivalent.
Prescribing
Information
|
